SCHEMBL17599359

SCHEMBL17599359

Nc1ccc(-c2cccc(C(=O)O)c2F)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.50
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47
NR4A3 Q92570 1/20 0.47
KEAP1 Q14145 3/20 0.43
NFE2L2 Q16236 2/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
MYC P01106 1/20 0.42
NSD2 O96028 2/20 0.42
HSD17B10 Q99714 1/20 0.42
MMP2 P08253 1/20 0.42
IDO1 P14902 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7908424 0.88 BTK (0.43) CDC25BKEAP1NFE2L2CRHBPCRHR2
SCHEMBL19923221 0.81 HSD17B10 (0.59) NR4A1NR4A2NR4A3MYCHSD17B10
SCHEMBL22684102 0.78 MYC (0.45) KEAP1MYCHSD17B10MMP2IDO1
SCHEMBL27795732 0.75 ALDH1A1 (0.55) CDC25BNR4A1NR4A2NR4A3MYC
SCHEMBL121804 0.74 HNF4A (0.63) CDC25BMYCHSD17B10ALDH1A1KMT2A
SCHEMBL629199 0.74 CDC25B (0.54) CDC25BNR4A1NR4A2NR4A3KEAP1
SCHEMBL689824 0.74 CDC25B (0.64) CDC25BNR4A1NR4A2NR4A3NSD2
SCHEMBL602307 0.74 MMP2 (0.61) CDC25BNR4A1NR4A2NR4A3KEAP1
SCHEMBL31227767 0.74 MMP2 (0.61) CDC25BNR4A1NR4A2NR4A3KEAP1
SCHEMBL29549315 0.74 CDC25B (0.64) CDC25BNR4A1NR4A2NR4A3NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed